Spinal Cord Neural Stem Cell Generation via Morphogen Patterning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are unable to generate sufficient numbers of karyotypically stable, appropriately patterned neural stem cells with spinal cord positional identity for effective implantation and functional engraftment in treating spinal cord injuries and neurologic diseases.
Innovation Solution
The methods involve culturing human pluripotent stem cells in the presence of caudalizing morphogens and SMAD inhibitors to induce and maintain spinal cord neural stem cells and progenitor cells, ensuring their expansion, differentiation, and retention of spinal cord positional identity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If neural stem cells are generated from human pluripotent stem cells using conventional methods, then cell production is achieved, but the cells lack spinal cord positional identity and karyotypic stability
Solution Approach 1:
The patent applies preliminary action by pre-specifying the spinal cord regional identity through controlled exposure to caudalizing morphogens (such as retinoic acid) and SMAD inhibitors during the neural stem cell induction process. This preliminary patterning ensures that the generated cells inherently possess the correct spinal cord positional identity before implantation, resolving the contradiction between manufacturing precision and method complexity.
2Quantity of substance
If neural stem cells are expanded in culture to obtain sufficient numbers, then cell quantity increases, but karyotypic stability is compromised
Solution Approach 1:
The patent employs parameter changes by optimizing specific culture conditions including the use of SMAD inhibitors (such as LDN-193189 and SB-431542) and caudalizing morphogens at controlled concentrations. These parameter adjustments maintain karyotypic stability during cell expansion while achieving sufficient cell numbers for therapeutic application, resolving the contradiction between quantity and reliability.
3Reliability
If conventional neural stem cell methods are used, then cell generation is achieved, but the cells fail to survive and engraft functionally in spinal cord injury models
Solution Approach 1:
The patent applies local quality by inducing specific spinal cord regional identity (caudal identity) in the neural stem cells through localized exposure to caudalizing morphogens and SMAD inhibitors. This creates cells with the precise local characteristics needed for successful engraftment in spinal cord injury models, resolving the contradiction between engraftment success and manufacturing simplicity.
4Manufacturing precision
If spinal cord neural stem cells are induced using caudalizing morphogens and SMAD inhibitors, then spinal cord positional identity is achieved, but the culture process becomes more complex
Solution Approach 1:
The patent applies preliminary action by pre-establishing the spinal cord patterning through controlled induction with caudalizing morphogens and SMAD inhibitors before the cells are expanded or implanted. This preliminary specification of identity simplifies subsequent steps while ensuring precise spinal cord patterning, resolving the contradiction between manufacturing precision and protocol complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These methods generate karyotypically stable spinal cord neural stem cells that can survive, engraft, and differentiate into functional neural cells in vivo, supporting corticospinal regeneration and establishing connectivity with host spinal cord neurons.
Implementation Method 1
culturing the cells in the presence of caudalizing morphogens (compounds causing development of spinal cord patterning)
Implementation Method 2
SMAD inhibitors (SMAD is an allusion to this family of proteins' homology with the Caenorhabditis elegans SMA and Drosophila MAD family of genes)
Implementation Method 3
an activator of WNT signaling. In some embodiments, the activator of WNT signaling is CHIR99021
Implementation Method 4
the activator of SHH is Hh-Ag1.5
Data Source
AI summary
Spinal cord neural stem cells (NSCs) have great potential to reconstitute damaged spinal neural circuitry. In some embodiments, derivation of spinal cord NSCs from human pluripotent stem cells (hPSCs) is described. These spinal cord NSCs can differentiate into a diverse population of spinal cord neurons comprising multiple positions in the dorso-ventral axis, and can be maintained for prolonged time periods. After grafting into injured spinal cords, grafts may be rich with excitatory neurons, extend large numbers of axons over long distances, innervate their target structures, and enable robust corticospinal regeneration. In some embodiments, hPSC-derived spinal cord NSCs enable a broad range of biomedical applications for in vitro disease modeling, and can provide a clinically-translatable cell source for spinal cord “replacement” strategies in several spinal cord disorders.